Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are ...

How Does Arynta Work for Binge Eating Disorder? The main ingredient in Arynta is lisdexamfetamine, a central nervous system (CNS) stimulant. It is not clear how lisdexamfetamine works for binge eating ...

Binge-eating disorder is the most prevalent eating disorder in the United States, but previous studies have presented conflicting views of the disorder's duration and the likelihood of relapse. A new ...

Binge eating disorder is the most common type of eating disorder in the U.S. Binge eating is characterized as eating large amounts of food in a short period, typically under two hours. People with ...

Binge eating disorder (BED) affects people of all ages, genders and ethnicities, and is the most common eating disorder in the United States. Individuals with BED repeatedly engage in excessive food ...

Prior studies have suggested that binge eating disorder may not last long, but a more rigorous look at the illness finds that just isn't so. "The big takeaway is that binge-eating disorder does ...

Binge-eating disorder (BED) is characterized by recurrent binge-eating episodes not followed by the regular use of compensatory behaviors. Research indicates a lifetime prevalence of 0.42 percent in ...

Although binge eating disorder affects millions of Americans—considerably more than bulimia or anorexia—very few seek treatment, though updated assessment and treatment guidelines aim to fix that.

Binge-eating disorder (BED) often improves with time, but full remission can take many years and relapse is common, new research suggested. The study revealed that 61% individuals still suffered from ...

Sheeran didn’t explicitly name his diagnosis, and described seeing his own experience reflected in Elton John’s memoir. “I found myself doing what Elton talks about in his book—gorging, and then it ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers. Lisdexamfetamine, marketed as Vyvanse, first ...